Xavier Matias-Guiu Guia
Grado: Doctor/a
973 705 340
fjmatiasguiu.lleida.ics(ELIMINAR)@gencat.cat
ResearcherID: http://www.researcherid.com/rid/C-3039-2009
Grupos
Publicaciones
-
de la Rosa, I; Sisó, P; Ríos, C; Gracia, J; Cuevas, D; Maiques, O; Eritja, N; Soria, X; Angel-Baldó, J; Gatius, S; Sanchez-Moral, L; Sarrias, MR; Matias-Guiu, X; Martí, RM; Macià, A
High Copy Number Variations Correlate with a Pro-Tumoral Microenvironment and Worse Prognosis in Acral Lentiginous Melanoma
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 26 -. .
-
Meijs-Hermanns, P; Werner, HMJ; Kooreman, L; Bretova, P; Weinberger, V; Vrede, S; Alcala, LSM; Amant, F; Asberger, J; Bednarikova, M; Boll, D; Bronkhorst, CM; Bulten, J; Gil-Moreno, A; Haldorsen, IS; Hausnerova, J; Huvila, J; Koskas, M; Krakstad, C; Kuesters-Vandevelde, H; Moreno, GM; Matias-Guiu, X; Ngo, H; Pijlman, BM; Santacana, M; Smink, M; Troviko, J; Verhoef, VMJ; van de Vijver, K; van Hamont, D; van der Wurff, AAM; Pijnenborg, JMA; Visser, NCM
Improving pre-operative binary grading: relevance of p53 and PR expression in grade 2 endometrioid endometrial carcinoma
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER 35 101682-101682. .
-
Eloy, C; Fraggetta, F; van Diest, PJ; Polónia, A; Curado, M; Temprana-Salvador, J; Zlobec, I; Purqueras, E; Weis, CA; Matias-Guiu, X; Schirmacher, P; Ryska, A
Digital transformation of pathology - the European Society of Pathology expert opinion paper
VIRCHOWS ARCHIV -. .
-
Rodriguez, JV; Piñol, M; Sorolla, MA; Parisi, E; Sorolla, A; Santacana, M; Ruiz, M; Parra, G; Bernabeu, M; Iglesias, M; Aracil, C; Escartin, A; VILARDELL, F; Matias-Guiu, X; Salud, A; Montal, R
Comprehensive immunophenotyping of gastric adenocarcinoma identifies an inflamed class of tumors amenable to immunotherapies
Journal for ImmunoTherapy of Cancer 13 -. .
-
Matias-Guiu, X; Temprana-Salvador, J; Lopez, PG; Kammerer-Jacquet, SF; Rioux-Leclercq, N; Clark, D; Schürch, CM; Fend, F; Mattern, S; Snead, D; Fusco, N; Guerini-Rocco, E; Rojo, F; Brevet, M; Tellez, MS; Dei Tos, A; di Maio, T; Ramírez-Peinado, S; Sheppard, E; Bannister, H; Gkiokas, A; Arpaia, M; Ben Dhia, O; Martino, N
Implementing digital pathology: qualitative and financial insights from eight leading European laboratories
VIRCHOWS ARCHIV -. .
-
Maiques, O; Sallan, MC; Laddach, R; Pandya, P; Varela, A; Crosas-Molist, E; Barcelo, J; Courbot, O; Liu, YB; Graziani, V; Arafat, Y; Sewell, J; Rodriguez-Hernandez, I; Fanshawe, B; Jung-Garcia, Y; Imbert, PRC; Grasset, EM; Albrengues, J; Santacana, M; Macià, A; Tarragona, J; Matias-Guiu, X; Marti, RM; Tsoka, S; Gaggioli, C; Orgaz, JL; Fruhwirth, GO; Wallberg, F; Betteridge, K; Reyes-Aldasoro, CC; Haider, S; Braun, A; Karagiannis, SN; Elosegui-Artola, A; Sanz-Moreno, V
Matrix mechano-sensing at the invasive front induces a cytoskeletal and transcriptional memory supporting metastasis
Nature Communications 16 1394-1394. .
-
Rodríguez-Martínez, A; Torrejón-Escribano, B; Eritja, N; Dorca-Arévalo, J; Gabaldón, C; Sévigny, J; Matias-Guiu, X; Martín-Satué, M
Endometrial epithelial cell organoids as tools for studying the CD39 family of enzymes and for validating enzyme inhibitors
HISTOLOGY AND HISTOPATHOLOGY 40 171-182. .
-
Quesada, S; Penault-Llorca, F; Matias-Guiu, X; Banerjee, S; Barberis, M; Coleman, RL; Colombo, N; Defazio, A; Mcneish, IA; Nogueira-Rodrigues, A; Oaknin, A; Pignata, S; Pujade-Lauraine, É; Rouleau, E; Ryska, A; van der Merwe, N; Van Gorp, T; Vergote, I; Weichert, W; Wu, XH; Ray-Coquard, I; Pujol, P
Homologous recombination deficiency in ovarian cancer: Global expert consensus on testing and a comparison of companion diagnostics
EUROPEAN JOURNAL OF CANCER 215 115169-115169. .
-
Vredea, SW; Van Weelden, WJ; Bulten, J; Gilks, CB; Teerenstra, S; Huvila, J; Matias-Guiu, X; Gil-Moreno, A; Asbergerj, J; Sweegers, S; van der Putten, LJM; Kuesters-Vandevelde, HVN; Reijnen, C; Colasi, E; Hausnerova, J; Weinberger, V; Snijders, MPLM; Vinklerova, P; Ravaggi, A; Odicino, F; Bignotti, E; Mcalpine, JN; Kruitwagen, R; Pijnenborga, JMA
Hormonal biomarkers remain prognostically relevant within the molecular subgroups in endometrial cancer
GYNECOLOGIC ONCOLOGY 192 15-23. .
-
Matias-Guiu, X; Raspollini, MR; Kulka, J; Ryska, A; Dieri, RA; Schirmacher, P; European Society of Pathology ESP
The role of the pathologist in the design and conducting of biomarker-driven clinical trials in cancer: position paper of the European Society of Pathology
VIRCHOWS ARCHIV 486 207-214. .
-
Moreno-Moreno, E; Caniego-Casas, T; Carretero-Barrio, I; Cortés, A; Muriel, A; Domínguez-Rullán, JA; Martín-Gromaz, C; Moreno-Bueno, G; Matías-Guiu, X; Palacios, J; Pérez-Mies, B
Histologic and Molecular Type Changes in Endometrial Cancer Recurrences in Comparison With Their Corresponding Primary Tumors
AMERICAN JOURNAL OF SURGICAL PATHOLOGY 48 1580-1587. .
-
Matias-Guiu, X; Lax, S; Raspollini, MR; Palacios, J; Zheng, WX; Liu, CR; de Brot, L; Lordello, L; Hardisson, D; Gaffney, D; Mutch, D; Scambia, G; Creutzberg, CL; Fotopoulou, C; Berek, JS; Concin, N
FIGO 2023 staging for endometrial cancer, when, if it is not now?
EUROPEAN JOURNAL OF CANCER 213 115115-115115. .
Proyectos
- Unravelling the molecular and phenotypic complexity of endometriosis through new models and omics integration: towards a personalized clinical management
- Homologous recombination deficiency in high-grade endometrial cancers. Biomarkers and impact of intratumor heterogeneity.
- EPH Receptor Signaling in Endometrial Cancer
- Ajuts per a la contractació de personal investigador novell (FI)
- Personalized Immunotherapy for Endometrial Cancer; Acronym: ExCITE (Endometrial Cancer Immunotherapy)
- "Multi-Omics data for Cancer Research and the Development of New Diagnostics and Therapies"
- EFFICACY: Nuevas estrategias para incrementar efectividad de los tratamientos con ABTL0812
- Perfiles epigenéticos asociados a patrones de metastasis en cáncer de endometrio
- CONTRACTES D'INCORPORACIO DE CIENTIFICS I TECNOLEGS: INCORPORACIO D'UNA DOCTORA PER A L'ACCIO ANTITUMORAL DELS CANNABINOIDES EN EL CARCINOMA D'ENDOMETRI
- DISCOVERY, VALIDATION AND IMPLEMENTATION OF BIOMARKERS FOR PRECISION ONCOLOGY
- Desarrollo de nuevas aproximaciones en el manejo individualizado de pacientes con cancer ginecológico (PREDICTGYN)
- VALIDACION DE ANEXINA 2 COMO PREDICTOR DE RECIDIVA EN EL CANCER DE ENDOMETRIO. DISEÑO DE NUEVAS ESTRATEGIAS TERAPEUTICAS. ANXARECU
